Kaldyum (Potassium Chloride)

After oral ingestion, potassium chloride dissociates into potassium ions that are absorbed into the bloodstream. The increased extracellular potassium corrects the electrochemical gradient across cell membranes, enabling proper nerve impulse transmission, muscle contraction, and cardiac rhythm maintenance.

The dosage of Kaldyum is individualized. A qualified prescriber determines the appropriate strength and frequency based on the patient’s serum potassium level, renal function, and overall clinical condition. Patients should follow the prescribing information provided by their healthcare professional.

Safety data for Kaldyum in pregnancy and lactation are limited. Use only if the potential benefit justifies any potential risk to the fetus or infant. Healthcare providers should evaluate each case carefully and monitor potassium levels closely if therapy is required.

To order Kaldyum, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, confirming trade or institutional credentials before providing pricing, availability, shipping details, and any necessary import documentation.

Kaldyum provides potassium chloride, the most common and bioavailable form of oral potassium supplementation. Compared with potassium gluconate or citrate, chloride offers a higher elemental potassium content per milligram, making it efficient for rapid correction of low serum potassium.

Kaldyum should be stored at temperatures below 25 °C, in its original packaging, protected from moisture and direct sunlight. Keeping the product in a dry, cool environment helps maintain its stability and potency throughout its shelf life.

Kaldyum is taken orally, usually with a full glass of water. The exact administration schedule—such as with meals or on an empty stomach—depends on the prescriber’s instructions and the patient’s tolerance. Swallow tablets or capsules whole; do not crush or chew unless directed.

The most serious risks include hyperkalemia, which can cause cardiac arrhythmias, muscle weakness, and potentially life‑threatening heart rhythm disturbances. Patients with renal impairment or those taking other potassium‑increasing drugs are at higher risk and require close monitoring.

Kaldyum should be avoided in individuals with known hyperkalemia, severe renal failure, or those on concurrent high‑dose potassium‑sparing therapies unless closely supervised by a healthcare professional. Patients with a history of allergic reactions to potassium chloride should also refrain from using the product.